
Rigel Pharmaceuticals RIGL
€ 24.84
1.84%
Quartalsbericht 2026-Q1
hinzugefügt 05.05.2026
Rigel Pharmaceuticals EV 2011-2026 | RIGL
EV Jährlich Rigel Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 679 M | 497 M | 139 M | 149 M | 555 M | 660 M | 463 M | 301 M | 484 M | 202 M | 240 M | 192 M | 272 M | 467 M | 617 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 679 M | 139 M | 394 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
4.15 M | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
6.3 M | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-4.92 M | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-5.73 M | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-1.83 M | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 6.82 | 1.94 % | $ 187 M | ||
|
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | ||
|
IMV
IMV
|
23.6 M | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
17.1 B | $ 90.36 | 2.93 % | $ 21.8 B | ||
|
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.62 | -0.61 % | $ 431 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
106 M | $ 2.71 | -0.92 % | $ 253 M | ||
|
Anika Therapeutics
ANIK
|
156 M | $ 15.14 | 2.16 % | $ 217 M | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
4.35 M | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 3.39 | 2.91 % | $ 5.58 M | ||
|
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
335 M | $ 1.51 | 2.03 % | $ 177 M | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 20.47 | 4.97 % | $ 2.6 B | ||
|
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
4.02 M | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M |